• A Comparative Analysis of Hidradenitis Suppurativa and Acne Inversa Webpages
• A state-of-the-art systematic review of cancer in hidradenitis suppurativa
• Addressing the unmet care needs of people with hidradenitis suppurativa
• Adopting adalimumab combined surgery in the management of moderate to severe hidradenitis suppurativa: Experience from a single medical center in southern Taiwan
• Advances in Hidradenitis Suppurativa Pathogenesis and Therapies from the Symposium on HS Advances 2023
• Anakinra in Pyogenic Arthritis, Acne, Pyoderma Gangrenosum, and Suppurative Hidradenitis (PAPASH) Spectrum Disorder: A Case Report and Literature Review
• Analysing common topics of secure patient messages in hidradenitis suppurativa: a text-embedding and natural language-processing approach
• Anti-IL17 Secukinumab in hidradenitis suppurativa: A long-term drug survival analysis
• Antimicrobial Resistance Trends in Hidradenitis Suppurativa Lesions
• Assessment of Hidradenitis Suppurativa Specialty Care in Dermatology Residency Programs Across the United States
• Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis
• Beyond caregiving: Navigating life with a developmentally disabled daughter with a severe case of Hidradenitis Suppurativa
• Biologic drugs in hidradenitis suppurativa: what does the GP have to know? A narrative review
• Brepocitinib, a potent and selective TYK2/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis
• Case report: A case of widespread soft tissue infection and multiple abscesses secondary to hidradenitis suppurativa inducing septic shock caused by Lawsonella clevelandensis in China
• Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
• Clinical characteristics and risk factors for secondary lymphoedema in hidradenitis suppurativa
• Clinical Features of Hidradenitis Suppurativa among Elderly: Insights from a Large Multicenter Tertiary Cohort
• Clinical Significance and Microbiological Characteristics of <em>Staphylococcus lugdunensis</em> in Cutaneous Infections
• Combination Therapy of Oral LDN and Topical Pentoxifylline, Rifampin, Clindamycin for Hidradenitis Suppurativa
• Commentary on "Staged Regional Deroofing for the Treatment of Extensive Hidradenitis Suppurativa"
• Comorbidities, Clinical Presentation, Subtypes, and Treatment of HS Patients in Lithuania
• Comparative transcriptome analysis of acne vulgaris, rosacea, and hidradenitis suppurativa supports high-dose dietary zinc as a therapeutic agent
• Compared burden of psoriasis, atopic dermatitis, hidradenitis suppurativa and chronic urticaria: baseline characteristics of the patients included in the OMCCI cohort, a French, prospective multicentre study of chronic inflammatory dermatoses
• Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort - A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses
• Complex hidradenitis suppurativa on a background of long-standing Crohn's disease requiring radical pelvic and perineal reconstruction: A case report
• DETERMINANT FACTORS OF DISEASE SEVERITY FOR PATIENTS WITH HIDRADENITIS SUPPURATIVA EVALUATED IN A SPANISH HOSPITAL OVER A 5-YEAR PERIOD
• Diabetes remission associated with optimized treatment of hidradenitis suppurativa
• Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
• Dysregulation of Aquaporin-3 and Glyceryl Glucoside Restoring Action in Hidradenitis Suppurativa in Vitro Models
• Effect of adalimumab treatment on inflammatory and hematological parameters in patients with Hidradenitis suppurativa
• Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa
• Efficacy of spironolactone in treating hidradenitis suppurativa in women of childbearing age: a single-center retrospective analysis
• Eosinophils in hidradenitis suppurativa patients exhibit pro-inflammatory traits, implicating a potential pathogenic role in the disease
• Ethical implications of dermatologists refusing to care for certain diseases
• Evaluating the Internet as a Source of Information for Patients With Hidradenitis Suppurativa: A Review of Websites' Content, Insights Into Engagement, and Access
• Evaluation of Cannabis-Related Product Use Among Patients With Hidradenitis Suppurativa: A Narrative Review
• Evaluation of post-surgical complications of hidradenitis suppurativa lesions explored with presurgical ultra-high frequency ultrasound mapping
• Fibromyalgia and Skin Disorders: A Systematic Review
• Financial impact on social security of the incorporation of adalimumab for the treatment of hidradenitis suppurativa: An analysis of the 61-million-contributor Brazilian Social Security System (INSS)
• Guselkumab - In Psoriasis and Beyond
• Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa
• Hepatocyte Growth Factor has Unique Functions in Keratinocytes that differs from IL-17A and TNF and may contribute to Inflammatory Pathways in Hidradenitis Suppurativa
• Hidradenitis suppurativa and cardiovascular diseases: A bidirectional Mendelian randomization study
• Hidradenitis suppurativa and psychosocial well-being: a cross-sectional survey analysis from the All of Us research program
• Hidradenitis Suppurativa in the SARS-CoV-2 Pandemic: Investigation of Trigger Factors in a Single Center
• Hidradenitis suppurativa patient requiring cardiac procedure with inguinal access: Case management with ertapenem
• Hidradenitis suppurativa: A prospective epidemiologic study in Albania
• Hidradenitis Suppurativa: New Targets and Emerging Treatments
• How Digital Solutions Might Provide a World of New Opportunities for Holistic and Empathic Support of Patients with Hidradenitis Suppurativa
• How to integrate surgery and targeted therapy with biologics for the treatment of hidradenitis suppurativa: Delphi consensus statements from an Italian expert panel
• Improving hidradenitis suppurativa management: consensus statements from physicians and patients' perspectives
• Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study
• Interleukin 1 Receptor-Associated Kinase 4 is Overexpressed in Hidradenitis Suppurativa Skin and Correlates with Inflammatory Biomarkers
• Introducing MCC-PS: a novel prognostic score for Merkel cell carcinoma
• Inverse psoriasis on pre-existing hidradenitis suppurativa lesions: Reply to "A case series of tumor necrosis factor inhibitor-induced psoriasis in patients with hidradenitis suppurativa"
• Investigation of the effect of adapalene 0.3%/benzoyl peroxide 2.5% gel in Korean patients with acne: a randomized, double-blind clinical trial, with a histopathological and immunohistochemical study
• IRAK4: A Novel Target in the Therapeutic Landscape of Hidradenitis Suppurativa?
• JAAD Game Changers: "Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States"
• Low rate of seroconversion analyzing QuantiFERON TB-gold testing in patients with psoriasis and hidradenitis suppurativa taking biologic therapy at an academic center in New York City
• Management of pain in the inpatient and non-surgical outpatient dermatology settings: A narrative review
• Metabolomic and lipidomic fingerprints in inflammatory skin diseases - Systemic illumination of atopic dermatitis, hidradenitis suppurativa and plaque psoriasis
• Monoclonal Antibodies in the Management of Inflammation in Wound Healing: An Updated Literature Review
• Multifocal pyoderma gangrenosum induced by secukinumab in a patient with hidradenitis suppurativa
• New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials
• Patient and Caregiver Experience of Accessing Information on Hidradenitis Suppurativa through Social Media
• Pediatric SAPHO syndrome with pleural effusion: case report of a unique finding in a rare disease
• Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
• Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study
• Presurgical Mapping With Ultra-high Frequency Ultrasound of Hidradenitis Suppurativa Lesions Treated With Wide Local Excision and Secondary Intention Healing
• Prevalence of abdominal aortic aneurysm in patients with hidradenitis suppurativa in the Veterans Affairs Health Care System
• Prevalence of Musculoskeletal Symptoms in Patients With Hidradenitis Suppurativa and Associated Factors: Cross-Sectional Study
• PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome: A case report and review of the literature
• Pyrin-associated autoinflammation with neutrophilic dermatosis: A case report
• Readability of Information Generated by ChatGPT for Hidradenitis Suppurativa
• Real‐World‐Effektivität und Sicherheit der LAight‐Therapie bei Patienten mit Hidradenitis suppurativa
• Relationship between circulating white blood cell count and inflammatory skin disease: a bidirectional mendelian randomization study
• Response to Chawla et al., "Response to Vu et al.'s "Efficacy of Moxifloxacin as a Mono-antibiotic Therapy for Hidradenitis Suppurativa: A Retrospective Cohort Study""
• Response to Vu et al.'s "Efficacy of Moxifloxacin as a Mono-antibiotic Therapy for Hidradenitis Suppurativa: A Retrospective Cohort Study"
• Retraction: Review of Scoring Systems for Hidradenitis Suppurativa
• Saxophone Penis: A Forgotten Manifestation of Hidradenitis Suppurativa
• Scrofuloderma with extended lymphadenopathy: a rare presentation of tuberculosis mimicking hidradenitis suppurativa
• Self-perceived Burden, Impairment in Quality of Life and Sexual Functioning, and Further Implications in Patients with Vulvar Lichen Sclerosus: A Narrative Review and Personal Experience
• Sensitive detection of quality of life impact with a hidradenitis suppurativa specific measure
• Skin homeostasis is impaired in hidradenitis suppurativa lesions, a comparative study
• Smoking Cessation and Hidradenitis Suppurativa: Advances and Treatment Gaps
• Smoking Cessation and Risk of Hidradenitis Suppurativa Development
• Social Determinants of Health and Hidradenitis Suppurativa Disease Severity: A Geocoded Analysis
• Surgical outcomes of hidradenitis suppurativa: evaluating factors influencing recurrence and complications after 284 complete excisions
• Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis, Palmoplantar Pustulosis, and Neutrophilic Dermatoses: A GRAPPA 2023 Annual Meeting Update
• The Disease Burdens of Self-diagnosed Hidradenitis Suppurativa Patients in Japan: A Cross-sectional Web-based Survey
• The Efficacy and Safety of Biosimilars in Hidradenitis Suppurativa: A Comprehensive Review
• The epithelial transcriptome of hidradenitis suppurativa tunnels is more similar to cutaneous squamous cell carcinoma than to benign infundibular cysts
• The potential of Bruton's tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease
• The role of diet in managing hidradenitis suppurativa: a review of current evidence and future directions
• The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa
• Treatment of hidradenitis suppurativa with 755-nm alexandrite laser hair removal: A randomized controlled trial
• Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II trials reduced indices of systemic inflammation, recognised risk factors for cardiovascular disease
• Ultrasonography of Facial and Submandibular Hidradenitis Suppurativa and Concomitance with Acne Vulgaris
• Wound area severity index (WASI): A novel tool for assessing and predicting healing times in hidradenitis suppurativa postsurgical wounds